Discontinuation report ZERIT - CAP 30MG

Last updated on 2020-04-01 History
Report ID 55459
Drug Identification Number 02216108
Brand name ZERIT - CAP 30MG
Common or Proper name STAVUDINE
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) STAVUDINE
Strength(s) 30MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 60
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-03-31
Actual discontinuation date 2020-03-31
Remaining supply date 2020-03-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply All strengths are being deleted.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-11 English Compare
v2 2018-07-11 French Compare
v3 2020-04-01 English Compare
v4 2020-04-01 French Compare

Showing 1 to 4 of 4